Base de données sur les brevets canadiens / Sommaire du brevet 2989163 

Énoncé de désistement de responsabilité concernant l'information provenant de tiers

Une partie des informations de ce site Web à été fournie par des sources externes. Le gouvernement du Canada n'assume aucune responsabilité concernant la précision, l'actualité ou la fiabilité des informations fournies par les sources externes. Les utilisateurs qui désirent employer cette information devraient consulter directement la source des informations. Le contenu fournit par les sources externes n'est pas assujetti aux exigences sur les langues officielles, la protection des renseignements personnels et l'accessibilité.

Disponibilité de l'Abrégé et des Revendications

L'apparition de différences dans le texte et l'image des Revendications et de l'Abrégé dépend du moment auquel le document est publié. Les textes des Revendications et de l'Abrégé sont affichés :

  • lorsque la demande peut être examinée par le public;
  • lorsque le brevet est émis (délivrance).
(12) Demande de brevet: (11) CA 2989163
(54) Titre français: DISPOSITIF DE TRAITEMENT DE LA CROISSANCE CAPILLAIRE PAR PHOTOTHERAPIE
(54) Titre anglais: HAIR GROWTH LIGHT THERAPY DEVICE
(51) Classification internationale des brevets (CIB):
  • A61N 5/06 (2006.01)
(72) Inventeurs :
  • TAPPER, JAY (Etats-Unis d'Amérique)
  • BLAUSTEIN, LAWRENCE, A. (Etats-Unis d'Amérique)
  • SHUTER, DAVID (Etats-Unis d'Amérique)
  • ALTHOFF, CHARLES, PETER (Etats-Unis d'Amérique)
  • DING, LULIN (Etats-Unis d'Amérique)
(73) Titulaires :
  • JOHNSON & JOHNSON CONSUMER INC. (Etats-Unis d'Amérique)
(71) Demandeurs :
  • JOHNSON & JOHNSON CONSUMER INC. (Etats-Unis d'Amérique)
(74) Agent: SMART & BIGGAR
(74) Co-agent:
(45) Délivré:
(86) Date de dépôt PCT: 2016-06-22
(87) Mise à la disponibilité du public: 2016-12-29
(30) Licence disponible: S.O.
(30) Langue des documents déposés: Anglais

(30) Données de priorité de la demande:
Numéro de la demande Pays / territoire Date
14/747,464 Etats-Unis d'Amérique 2015-06-23

Abrégé français

L'invention concerne une dispositif de traitement de la croissance capillaire par photothérapie comprenant une plateforme. Selon un exemple de mode de réalisation, l'invention concerne un dispositif de photothérapie comprenant une plateforme de lampes thérapeutiques à porter comprenant une pluralité de lampes radiantes et une paroi réfléchissante disposée de manière à émettre l'énergie rayonnante à partir de la pluralité des lampes radiantes sur une zone de traitement de l'utilisateur, y compris le cuir chevelu de l'utilisateur ; la plateforme de lampes à porter comprend un bandeau associé de manière opérationnelle au support de la pluralité des lampes radiantes et de la paroi réfléchissante sur le cuir chevelu de l'utilisateur.


Abrégé anglais

Disclosed is a therapeutic lamp platform hair growth device. According to an exemplary embodiment, disclosed is a phototherapy device comprising a wearable therapeutic lamp platform including a plurality of radiant lamps and a reflective wall disposed to communicate radiant energy from the plurality of radiant lamps to a user treatment area including a scalp of the user, and the wearable lamp platform including a headband operatively associated with supporting the plurality of radiant lamps and reflective wall above the user's scalp.


Note : Les revendications sont présentées dans la langue officielle dans laquelle elles ont été soumises.


1. A phototherapy device comprising:
a wearable therapeutic lamp platform including a plurality of radiant lamps
and a reflective wall disposed to communicate radiant energy from the
plurality of
radiant lamps to a user treatment area including a scalp of the user, and the
wearable
lamp platform including a headband operatively associated with supporting the
plurality
of radiant lamps and reflective wall above the user's scalp.
2. The phototherapy device according to claim 1, wherein the wearable lamp
platform includes a comp operatively associated with a layout of the plurality
of radiant
lamps to part the user's hair to expose the scalp proximately located near the
plurality of
radiant lamps.
3. The phototherapy device according to claim 1, wherein the headband is
configured to pivotally attach to ears of the user.
4. The phototherapy device according to claim 1, wherein a wavelength of
the radiant energy is associated with hair growth.
5. The phototherapy device according to claim 1, wherein the lamp platform
is configured to locate the plurality of radiant lamps proximate to one or
more of the
user's part lines, recessed hairline and crown.
6. The phototherapy device according to claim 1, further comprising:
a plurality of light pipes operatively associated with the plurality of
radiant
lamps, the light pipes configured to direct the radiant energy to the user
treatment area.
7. The phototherapy device according to claim 1, wherein the light pipe
narrows a cone of radiant energy communicated from the radiant lamp.

37


8. A phototherapy device comprising:
a wearable therapeutic lamp platform including a plurality of radiant lamps
disposed to communicate radiant energy from the plurality of radiant lamps to
a user
treatment area including a scalp of the user, and the wearable lamp platform
including a
helmet operatively associated with supporting the plurality of radiant lamps
five above
the user's scalp.
9. The phototherapy device according to claim 8, wherein the wavelength of
the radiant energy is associated with hair growth.
10. The phototherapy device according to claim 8, wherein the lamp platform

is configured to locate the plurality of radiant lamps proximate to one or
more of the
user's part lines, recessed hair line and crown.
11. The phototherapy device according to claim 8, further comprising:
a reflective wall operatively attached to an inside surface of the helmet
and disposed to reflect radiant energy from the user treatment area back to
the user
treatment area.
12. The phototherapy device according to claim 8, further comprising:
a reflective wall having apertures for communicating the radiant energy to
the user treatment area, and at least a portion of the radiant lamps are
recessed relative
to the apertures.
13. The phototherapy device according to claim 8, further comprising:
a frame operatively attached to the helmet, the frame including ear rests to
support the lamp platform above the user's scalp.
14. The phototherapy device according to claim 13, wherein the frame is an
eyeglass frame.

38


15. The phototherapy device according to claim 8, further comprising:
an adjustable tensioner operatively attached to the helmet, the adjustable
tensioner configured to fit the helmet to a plurality of user head sizes.
16. The phototherapy device according to claim 8, further comprising:
eyeglass lenses operatively attached to the helmet.

39

Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
HAIR GROWTH LIGHT THERAPY DEVICE
[0001]
This application is a continuation-in-part of U.S. Patent Application No.
14/324,453, filed on July 7, 2014, which is a divisional of U.S. Patent
Application Serial
No. 13/604,012, filed September 5, 2012, now U.S. Patent No. 8,771,328, which
claims
priority from U.S. Provisional Patent Application Serial No. 61/532,140, filed
September
8, 2011, and this application is a continuation-in-part of U.S. Patent
Application Serial
No. 14/567,552, filed December 11, 2014, which claims priority to U.S.
Provisional
Patent Application Serial No. 61/914,624, filed December 11, 2013, the
disclosures of
which are incorporated herein by reference.
FIELD
[0002]
The present embodiments relate to devices and methods for delivering light-
based skin therapy treatments for improving skin health, such as anti-aging
enhancement or acne prevention, using light-emitting diode (LED) light
therapy,
although other types of light radiating sources can be used.
BACKGROUND
[0003]
Certain light spectrums emitted by LEDs (blue or red) are known to be
therapeutic for skin treatment against maladies such as acne, or are
beneficial to inhibit
skin aging. However, there is a need to provide users/patients with a
convenient at-
home light therapy delivery device such as a wearable mask, veil or hood that
is
adjustable or flexible to conform to different sizes and shapes, and that is
simple to use
without user discomfort. Currently available at-home, consumer usable products
on the
market are fixed to one-size and/or usually have to be hand-held; which
generally have
not proven satisfactory for providing the best or desired light dispersion.
The alternative
is customers visiting a doctor's office to receive treatments.
[0004]
Prior known light therapy devices, particularly masks, have suffered from
problems relating to the exposure of the LEDs and the associated circuitry to
power the
LEDs to contact by users.
More particularly, in an effort to maximize light

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
communication to a patient, the LEDs have been disposed in a manner which
allow
them to be physically engaged (e.g., touched) by a patient, or even contact a
treatment
surface, which processes are debilitating to the LEDs as a result of the
accumulation of
dirt and oil. In addition, any such engagement can be dangerous to patients
who are
exposed to the sharp or hot edges of the LEDs and the associated circuitry.
The
exposure of detailed circuitry presents an intimidating and unpleasant
experience when
the therapy requires several minutes of time for completion and the mask is
disposed
relatively close to the face, often causing an uncomfortable, claustrophobic
sensation
over time to the patient.
[0005]
A hands-free therapeutic experience is always better than having to hold the
device in a particular position for extended periods of time during the
therapy.
Numerous assemblies have been conceived for mounting masks and helmet-like
devices to varieties of straps, bands, wraps and cords, which can result in a
pressing of
the support and mounting assembly closely against the hair or scalp of a
patient. There
is always a need to minimize the extent of such attachment assemblies so that
on the
one hand the subject device is securely attached on the patient, but also that
the
attaching structure has minimal consequence to the patient's comfort during
the therapy
itself.
Being relatively light in weight, and easily and minimally supported during
therapeutic use are important to consumer acceptance.
[0006]
As users come in a variety of shapes and sizes, devices should be size or
area adjustable so that the therapy can be efficiently applied and/or
selectively
intensified to desired treatment areas.
[0007]
Lastly, particularly in therapeutic devices treating facial areas, eye
protection
is needed to avoid light damage or irritation to a patient's eyes. Prior known
devices
have typically used separable patches which must rest on the eye area to block
the
therapeutic light from communication to the eye system itself. There is a need
for a
better way that is readily adaptable to communicate therapeutic light to areas
near the
eyes, particularly with regard to anti-aging treatments, and still protect the
patient.
[0008]
It is desired to provide alternative means of using the benefits of the light
therapy in a manner to maximize therapeutic efficiencies in exposure while
maintaining
ease and convenience of use. For this reason, a variety of light weight,
flexible and
2

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
adjustable embodiments are disclosed within this disclosure incorporating a
variety of
energy varying applications responsive to user conditions or needs.
SUMMARY
[0009] The present embodiments comprise phototherapy systems and devices
comprising a therapeutic lamp platform for radiant lamps such as LEDs are
disposed in
an assembly comprising a first wall to which the lamps are affixed thereto and
a second
wall, closer to the patient, spaced from the first wall wherein the lamps are
recessed
relative thereto. The second wall comprises a reflective surface facing
towards a
patient and a plurality of light apertures substantially aligned with the LEDs
on the first
wall for communicating lamp radiation from the lamps to a user. The lamps and
associated circuitry are disposed between the first and second wall so that
the reflective
surface is relatively smooth and seamless towards the patient. The number of
lamps
are minimized, as is the circuitry therefor, and other assembly materials are
purposefully
selected for a relatively light weight assembly resulting in enhanced user
comfort during
therapy sessions. The walls have a malleable rigidity for flexible
adjustability relative to
the user. More particularly, the walls have a concave configuration relative
to the face
of the user which is adjustable relative to a rest position to be expandable
relative to a
size of the head of the user for a close fitting and secure engagement to the
user during
use. The device is mounted to the user with a frame comprising an eyeglass
frame or
goggles including lenses for shielding the user's eyes from lamp radiation.
The
adjustability of the embodiments is further enhanced by the walls being
pivotable
relative to the support frame and where the frames may include telescopic
temple arms
for selective adjustability relative to the head size of the user. The device
is thus
supported on the patient as a wearable hands-free mask or the like. A power
source
communicates energy to the lamps and comprises a remote battery pack and may
also
include a control processor for counting the number of uses by the device for
the user
and for indicating a need for device replacement after a predetermined number
of uses.
[0010] The present embodiments comprise an adjustable/flexible platform for
providing a light-based therapy that is adaptable to the user's receptive
surfaces,
whether based on size or condition, wherein the light therapy can be applied
without
3

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
limitation of the kind of light and without limitation of the ultimate purpose
of the therapy,
i.e., beauty, health, and/or wound healing. Such sources can vary in the form
of the
radiant energy delivery. Pulsed light (IPL), focused light (lasers) and other
methods of
manipulating light energy are encompassed within the present embodiments.
Other
methods of light emission may comprise continuous, pulsed, focused, diffuse,
multi
wavelength, single wavelength, visible and/or non-visible light wavelengths.
[0011] A present embodiment describes forms such as a shaped/fitted mask,
goggles, eye mask, shroud or hood, and facial mask (collectively referred to
as "mask")
with LED light emitted from LED bulbs or LED strips that are capable of being
adjusted
to accommodate the variances in face size or areas intended for therapeutic
attention.
Control systems are included to vary light intensity, frequency or direction.
[0012] The platform can be secured to the head by multiple means: eyeglass
frames,
straps, drawstring, harness, Velcro , turn dial or snap and buttons. As the
mask is
secured it can be adjusted upward, for chin to forehead coverage. It can also
be
adjusted outward, for side-to-side coverage. In addition, once the platform
has been
bent/slid to cover the face area, the distance of the platform from the skin
can be
adjusted for achieving a desired light intensity relative to a user's skin
surface. Thus,
the light therapy can be maximized in up to three physical dimensions.
[0013] The subject adjustability may be implemented through "smart"
processing and
sensor systems for enhanced flexibility/adjustability in the form of
adjustable energy
output, adjustable wavelengths, priority zones, timers, and the like. The
sensors of the
sensor systems will enable the subject embodiments to have the ability to
evaluate the
skin of the face and body of a patient with sensors for color, wrinkles, age
spots, acne,
lesion density, and the like, and plan a smart treatment, utilizing more or
less energy on
the priority zones. The subject embodiments can be smart from the standpoint
of skin
type, age, overall severity of problems and have the ability to customize the
treatment
accordingly.
[0014] In yet another embodiment, the phototherapy system device includes
an
aligned eye slot disposed for user to see through the device. Also included is
a
radiation absorbing layer interposed between the lamps and the outer wall.
4

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[0015] In yet another embodiment, the lamps are embedded in a flexible
sheet of
formable material and are integrally molded as strips within a material sheet.
[0016] In addition, control systems can measure or count device usage and
communicate historical usage, and indicate a time for replacement.
[0017] The present disclosure thus describes a fully flexible and
adjustable LED
device which provides improved usability and light dispersion.
[0018] According to another exemplary embodiment of this disclosure,
provided is a
therapeutic lamp platform controller comprising a power source; a control
circuit
operatively connected to the power source, the control circuit including one
or more
outputs to drive one or more radiant lamps associated with a therapeutic lamp
platform;
a user display; and a user control switch, the control circuit configured to
control one of
a plurality of therapeutic lamp platforms, each lamp platform including a
plurality of
radiant lamps including a unique mixed combination of different wavelength
radiant
energy disposed to communicate the radiant energy to a user treatment area.
[0019] According to still another exemplary embodiment of this disclosure,
provided
is a therapeutic lamp platform controller comprising a power source; a control
circuit
operatively connected to the power source, the control circuit including one
or more
outputs to drive one or more radiant lamps associated with the phototherapy
device; a
user display; and a user control switch, the control circuit configured to
control a plurality
of therapeutic lamp platforms, each therapeutic lamp platform including a
plurality of
radiant lamps including one or more wavelengths of radiant energy disposed to
communicate the radiant energy to a user treatment area.
[0020] According to yet another exemplary embodiment of this disclosure,
provided
is a therapeutic lamp platform controller comprising a power source; a control
circuit
operatively connected to the power source, the control circuit including one
or more
outputs to drive a plurality of radiant lamps associated with a therapeutic
lamp platform,
the plurality of radiant lamps including a mixed combination of different
wavelength
radiant energy and the plurality of radiant lamps disposed to communicate the
radiant
energy to a user treatment area; a user display operatively connected to the
control
circuit; and a user control switch operatively connected to the control
circuit, wherein the

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
control circuit is configured to control a dosage amount of radiant energy
communicated
to the user treatment area.
[0021] According to another exemplary embodiment of this disclosure,
provided is a
therapeutic lamp platform controller comprising a power source; a control
circuit
operatively connected to the power source, the control circuit including one
or more
outputs to drive a plurality of radiant lamps associated with a therapeutic
lamp platform,
the plurality of radiant lamps including a mixed combination of different
wavelength
radiant energy and the plurality of radiant lamps disposed to communicate the
radiant
energy to a user treatment area; a user display operatively connected to the
control
circuit; and, a user control switch operatively connected to the control
circuit, wherein
the control circuit is configured to limit a number of available doses from
the controller to
a predetermined number.
[0022] According to yet another exemplary embodiment of this disclosure,
provided
is a therapeutic lamp platform controller comprising a power source; a control
circuit
operatively connected to the power source, the control circuit including one
or more
outputs to drive a plurality of radiant lamps associated with a therapeutic
lamp platform,
the plurality of radiant lamps including a mixed combination of different
wavelength
radiant energy and the plurality of radiant lamps disposed to communicate the
radiant
energy to a user treatment area; a user display operatively connected to the
control
circuit; and a user control switch operatively connected to the control
circuit, wherein the
control circuit is configured to display on the user display the time
remaining for an
active dosage treatment session.
[0023] According to still another exemplary embodiment of this disclosure,
provided
is a therapeutic lamp platform controller comprising a power source; a control
circuit
operatively connected to the power source, the control circuit including one
or more
outputs to simultaneously drive a plurality of therapeutic lamp platforms; a
user display;
and a user control switch, the control circuit configured to simultaneously
control the
plurality of therapeutic lamp platforms, each therapeutic lamp platform
including a
plurality of radiant lamps disposed to communicate radiant energy to a user
treatment
area.
6

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[0024] According to another exemplary embodiment of this disclosure,
provided is a
therapeutic lamp platform controller comprising a down source; a control
circuit
operatively connected to the power source, the control circuit including one
or more
outputs to simultaneously drive a plurality of therapeutic lamp platforms; a
user display;
and a user control switch, the control circuit configured to simultaneously
control the
plurality of therapeutic lamp platform, each therapeutic lamp platform
including a
plurality of radiant lamps including a mixed combination of different
wavelength radiant
energy and the radian lamps disposed to communicate the radiant energy to a
user
treatment area.
[0025] According to yet another exemplary embodiment of this disclosure,
provided
is a method of charging a power source operatively associated with a
therapeutic lamp
platform, the therapeutic lamp platform including a plurality of radiant lamps
disposed to
communicate radiant energy to a user treatment area, a rechargeable power
source
operatively associated with powering the plurality of radiant lamps, a control
circuit
operatively associated with controlling a dosage of radiant energy provided to
the user
treatment area, and a charging port operatively associated with charging the
rechargeable power source from an external power source, the method comprising

connecting a power port of a computing device to the therapeutic lamp platform

charging port using an electrical cable; launching a charging software
application on the
computing device, the charging software application configuring the computing
device to
utilize a port operatively associated with the computing device to charge an
external
device; the computing device charging the therapeutic lamp platform
rechargeable
power source until the rechargeable power source reaches a substantially full
charge;
and disconnecting the electrical cable from the therapeutic lamp platform.
[0026] According to another exemplary embodiment of this disclosure,
provided is a
method of charging a power source operatively associated with a therapeutic
lamp
platform, the therapeutic lamp platform including a plurality of radiant lamps
disposed to
communicate radiant energy to a user treatment area, a rechargeable power
source
operatively associated with powering the plurality of radiant lamps, a control
circuit
operatively associated with controlling a dosage of radiant energy provided to
the user
treatment area, and a charging port operatively associated with charging the
7

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
rechargeable power source from an external power source, the method comprising

connecting a power port of a computing device to the therapeutic lamp platform

charging port using an electrical cable; the computing device charging the
therapeutic
lamp platform rechargeable power source until the rechargeable power source
reaches
a substantially full charge; and disconnecting the electrical cable from the
therapeutic
lamp platform.
[0027] According to still another exemplary embodiment of this disclosure,
provided
is a phototherapy device comprising a wearable therapeutic lamp platform
including a
plurality of radiant lamps and a reflective wall disposed to communicate
radiant energy
to a user treatment area; a frame for supporting the platform on a user; a
control circuit
operatively mounted to one of the wearable therapeutic lamp platform and the
frame; a
rechargeable power source operatively mounted to one of the wearable
therapeutic
lamp platform and the frame; and a charging port operatively mounted to one of
the
wearable therapeutic lamp platform and the frame, the charging port
operatively
associated with charging the rechargeable power source, wherein the
phototherapy
device is configured to be chargeable by a mobile communication device and an
electrical cable operatively connected to the phototherapy device charging
port and a
mobile communication device port configured to charge an external device.
[0028] According to another exemplary embodiment of this disclosure,
provided is a
phototherapy device comprising a wearable therapeutic lamp platform including
a
plurality of radiant lamps including a mixed combination of different
wavelength radiant
energy and a reflective wall with a plurality of radiant energy communication
areas
aligned with the radiant lamps and disposed to communicate the radiant energy
to a
user treatment area, and wherein the reflective wall is further formed to
disperse the
radiant energy over the user treatment area; a frame for supporting the
platform on a
user; a control circuit operatively mounted to one of the wearable therapeutic
lamp
platform and the frame; a rechargeable power source operatively mounted to one
of the
wearable therapeutic lamp platform and the frame; and a charging port
operatively
mounted to one of the wearable therapeutic lamp platform and the frame, the
charging
port operatively associated with charging the rechargeable power source,
wherein the
phototherapy device is configured to be chargeable by a mobile communication
device
8

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
and an electrical cable operatively connected to the phototherapy device
charging port
and a mobile communication device port configured to charge an external
device.
[0029] According to still another exemplary embodiment of this disclosure,
provided
is a phototherapy device comprising a wearable therapeutic lamp platform
including a
plurality of radiant lamps disposed to communicate radiant energy to a user
treatment
area; a power source; a controller operatively associated with the therapeutic
lamp
platform and the power source configured to limit a number of available doses
of radiant
energy provided to a user, and the controller configured to communicate with
an
ecommerce platform to obtain an additional number of available doses.
[0030] According to another exemplary embodiment of this disclosure,
provided is a
portable computing device operatively associated with an operatively connected

wearable therapeutic lamp platform, the portable computing device comprising
one or
more processors and operatively associated memory storing instructions, the
one or
more processors configured to execute the stored instructions to perform one
or more of
a) executing an ecommerce application for a user to purchase a number of
therapy
session dosages to be provided by the therapeutic lamp platform; b) monitoring
a
number of available therapy session dosages available on the therapeutic lamp
platform; c) perform diagnostics on the therapeutic lamp platform; d)
monitoring the
remaining time for an active therapy session dosage being provided by the
therapeutic
lamp platform; and e) controlling an execution of a therapy session dosage,
wherein the
portable computing device initiates the start of the therapy session dosage.
[0031] According to another exemplary embodiment of this disclosure,
provided is a
phototherapy system comprising a phototherapy device including a plurality of
radiant
lamps disposed to communicate radiant energy to a user treatment area, a
rechargeable power source, and a controller operatively associated with
controlling a
delivery of the radiant energy to the user treatment area, wherein the
plurality of radiant
lamps, the rechargeable power source and controller are housed by a mask
shaped
therapeutic lamp platform wherein the phototherapy device is configured to
inductively
charge the rechargeable battery; and an inductive charger configured to charge
the
phototherapy device rechargeable battery.
9

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[0032] According to another exemplary embodiment of this disclosure,
provided is a
phototherapy device comprising a wearable therapeutic lamp platform including
a
plurality of radiant lamps including a mixed combination of different
wavelength radiant
energy, and a reflective wall with a plurality of radiant energy communication
areas
aligned with the radiant lamps and disposed to communicate the radiant energy
to a
user treatment area and a frame for supporting the platform on a user; wherein
the
reflective wall is further formed to disperse the radiant energy over the
treatment area,
and the lamp platform includes an inductively chargeable power system.
[0033] According to yet another exemplary embodiment of this disclosure,
provided
is a phototherapy device comprising a therapeutic lamp platform including a
mask
including a plurality of radiant lamps having a mixed combination of different
wavelength
radiant energy and disposed to communicate the radiant energy to a user
treatment
area, the plurality of radiant lamps further disposed to provide radiant
therapy to provide
a first treatment session including a first set of wavelength radiant energy,
and a second
treatment session including a second set of wavelength radiant energy
including at least
one wavelength radiant energy not provided in the first treatment session; and
a frame
for supporting the mask on a user.
[0034] According to another exemplary embodiment of this disclosure,
provided is a
phototherapy device comprising a wearable therapeutic lamp platform including
a
plurality of radiant lamps including a mixed combination of different
wavelength energy
and a reflective wall with a plurality of radiant energy apertures aligned
with the radiant
lamps and disposed to communicate the radiant lamps and disposed to
communicate
the radiant energy to a user treatment area, and wherein the reflective wall
is further
formed to disperse the radiant energy over the treatment area; and a
controller
operatively associated operating the radiant lamps to provide a first
treatment session
including a first set of wavelength radiant energy, and a second treatment
session
including a second set of wavelength radiant energy including at least one
wavelength
radiant energy not provided in the first treatment session.
[0035] According to still another exemplary embodiment of this disclosure,
provided
is a phototherapy device comprising a wearable therapeutic lamp platform
including a
plurality of radiant lamps and a reflective wall disposed to communicate
radiant energy

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
from the plurality of radiant lamps to a user treatment area including a scalp
of the user,
and the wearable lamp platform including a headband operatively associated
with
supporting the plurality of radiant lamps and reflective wall above the user's
scalp.
[0036] According to yet another exemplary embodiment of this disclosure,
provided
is a phototherapy device comprising a wearable therapeutic lamp platform
including a
plurality of radiant lamps disposed to communicate radiant energy from the
plurality of
radiant lamps to a user treatment area including a scalp of the user, and the
wearable
lamp platform including a helmet operatively associated with supporting the
plurality of
radiant lamps five above the user's scalp.
BRIEF DESCRIPTION OF THE DRAWINGS
[0037] FIGURE 1 is a perspective view of one embodiment of a therapeutic
lamp
platform comprising a wearable mask;
[0038] FIGURE 2 is another perspective view of the device of FIG. 1;
[0039] FIGURE 3 is an exploded perspective view of FIG. 1;
[0040] FIGURE 4 is an exploded perspective view of FIG. 2;
[0041] FIGURE 5 is an exploded perspective view of the controller B;
[0042] FIGURE 6 is a cross-sectional view showing a two-wall structure of
the
embodiment of FIG. 1 wherein an inner wall includes light apertures aligned
with the
LEDs for communicating the therapeutic light to the user;
[0043] FIGURE 7 is a second cross-sectional view taken along a vertical
center-line;
[0044] FIGURE 8 is a partial cross-sectional perspective view illustrating
disposition
of recessed LED lamps relative to inner wall apertures;
[0045] FIGURE 9 is a perspective view of an alternative embodiment wherein
the
power supply and control circuitry are integrally formed with the mask
assembly;
[0046] FIGURE 10 is an exploded view of the device of FIG. 9;
11

CA 02989163 2017-12-11
WO 2016/209860
PCT/US2016/038612
[0047] FIGURE 11 is an exploded view of an alternative embodiment wherein the
mask walls are spaced by a flange;
[0048] FIGURE 12 is an embodiment of a packaging assembly containing the
device
of FIG. 1;
[0049] FIGURE 13 illustrates a try-me feature of the packaging of FIG. 11
wherein a
user can view a sample operation of the device;
[0050] FIGURE 14 is a flowchart of operational device control;
[0051] FIGURE 15 is an exploded view of an alternative embodiment including
a
see-through slot and a third light absorbing layer;
[0052] FIGURE 16 (A) (B) (C) and (D) are elevated views of the assembled
device of
FIGURE 15;
[0053] FIGURE 17 is an exploded view of an alternative embodiment including
eye
protecting goggles;
[0054] FIGURE 18 is an exploded view of an alternative embodiment having a
mask
sized for applying the LED therapy to the eye area;
[0055] FIGURES 19A and 19B illustrate a front view and side view
respectively of a
therapeutic lamp platform controller including a SIM cartridge refill
according to an
exemplary embodiment of this disclosure:
[0056] FIGURE 20 is a schematic of a first therapeutic lamp platform
controller as
shown in FIGURE 5, according to an exemplary embodiment of this disclosure;
[0057] FIGURE 21A is a perspective view of another second therapeutic lamp
platform controller according to an exemplary embodiment of this disclosure;
[0058] FIGURE 21 B is an exploded view of another second therapeutic lamp
platform controller according to an exemplary embodiment of this disclosure;
12
RECTIFIED SHEET (RULE 91) ISA/EP

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[0059] FIGURES 22A and 22B is a schematic of the second therapeutic lamp
platform controller shown in FIGURE 21, according to an exemplary embodiment
of this
disclosure;
[0060] FIGURE 23 is a flow chart of the operational control of a
therapeutic lamp
platform according to an exemplary embodiment of this disclosure, the
operational
control including a Stand-By Mode, Normal Mode, Test Mode and Configure Mode;
[0061] FIGURE 24 is a flow chart of the operational control of a Normal
Mode
associated with a therapeutic lamp platform controller according to an
exemplary
embodiment of this disclosure;
[0062] FIGURE 25 is a flow chart of the operational control of a Battery
Charge
Mode associated with a therapeutic lamp platform controller according to an
exemplary
embodiment of this disclosure;
[0063] FIGURE 26 is a flow chart of the operational control of a
Configuration Mode
associated with a therapeutic lamp platform controller according to an
exemplary
embodiment of this disclosure;
[0064] FIGURE 27 is a flow chart of the operational control of a Test Mode
associated with a therapeutic lamp platform controller according to an
exemplary
embodiment of this disclosure;
[0065] FIGURE 28 is a flow chart of the operational control of a Stand-By
Mode
associated with a therapeutic lamp platform controller including an
independent mask
controller configured to determine authorization of a mask/controller
combination,
according to an exemplary embodiment of this disclosure;
[0066] FIGURE 29 is a system diagram including a therapeutic lamp platform
controller simultaneously powering a plurality of phototherapy devices,
including an Eye
Mask, a Décolletage Device and a Hand Rejuvenation Device;
[0067] FIGURE 30 illustrates a mobile device operatively associated with
powering a
therapeutic lamp platform according to an exemplary embedment of this
disclosure;
13

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[0068] FIGURE 31 is a detail view of the mobile device shown in FIGURE 30;
[0069] FIGURES 32A and 32B illustrate a therapeutic lamp platform including
an
inductively charged mask with an integrated controller, rechargeable battery,
and
inductive charger, according to an exemplary embodiment of this disclosure;
[0070] FIGURES 33A and 33B show the docking of an inductively charged
therapeutic lamp platform on an inductive charger according to an exemplary
embodiment of this disclosure;
[0071] FIGURES 34A, 34B and 34C further illustrate the docking of an
inductively
chargeable therapeutic lamp platform according to an exemplary embodiment of
this
disclosure;
[0072] FIGURES 35A and 35B show a corded therapeutic lamp platform
including an
inductively charged controller and inductive charger;
[0073] FIGURE 36 is an exploded view of the inductively charged therapeutic
lamp
platform shown in FIGURE 32;
[0074] FIGURE 37 illustrates a combination therapeutic lamp platform mask
providing for a plurality of treatment radiation combinations, e.g. Acne and
Anti-Aging,
according to an exemplary embodiment of this disclosure;
[0075] FIGURE 38 illustrates another combination therapeutic lamp platform
mask
providing for a plurality of treatment radiation combinations, e.g. Acne and
Anti-Aging,
according to an exemplary embodiment of this disclosure;
[0076] FIGURES 39A and 39B illustrate a therapeutic lamp platform
configured to
stimulate hair growth according to an exemplary embodiment of this disclosure;
[0077] FIGURES 40A and 40B illustrate a therapeutic lamp platform
configured to
stimulate hair growth including an integrated comb according to an exemplary
embodiment of this disclosure;
14

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[0078] FIGURES 41A and 41B are detail views of LED/Brush Bristle
configurations
for a therapeutic lamp platform configured to stimulate hair growth;
[0079] FIGURES 42A and 42B are detail views of radiant energy scalp
coverage
associated with an exemplary embodiment of a therapeutic lamp platform
configured to
stimulate hair including LEDs without an associated light pipe, and with an
associated
light pipe, respectively;
[0080] FIGURES 43A and 43B are further detail views of radiant energy scalp
coverage associated with a therapeutic lamp platform without a light pipe and
with a
light pipe, respectively, as shown in FIGURES 42A and 42B;
[0081] FIGURES 44A and 44B illustrate another therapeutic lamp platform
configured to stimulate hair growth including an eye glass frame and
reflective layer,
according to an exemplary embodiment of this disclosure;
[0082] FIGURE 45 is a detail view of an LED configuration of a therapeutic
lamp
platform configured to stimulate hair growth as shown in FIGURES 44A and 44B;
[0083] FIGURES 46A and 46B illustrate another therapeutic lamp platform
configured to stimulate hair growth including a helmet according to an
exemplary
embodiment of this disclosure; and
[0084] FIGURE 47 is a detailed view of an LED configuration of a
therapeutic lamp
platform as shown in FIGURES 45A and 45B, configured to stimulate hair growth
according to an exemplary embodiment of this disclosure.
DETAILED DESCRIPTION
[0085] The subject embodiments relate to a phototherapy system including
methods
and devices, preferably comprising a wearable hands-free device with a remote
battery
pack for powering therapeutic lamps in the device. The subject devices display

numerous benefits including a light platform wherein the platform and the
lamps therein
are properly positionable relative to a user during use with no human touch.
That is,

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
structural componentry of the device not only supports the lamp platform on
the user,
but functions as a guide for the appropriate disposition of the lamps relative
to the
treatment areas of the user. The structural assembly of the device precludes
sharp or
hot surfaces from being engageable by a user as the lamps are recessed
relative to an
inner reflective surface closest to and facing the patient treatment surface.
Circuit
componentry to communicate power to the lamps is also encased within the wall
structure. Therapeutic light, shining through wall apertures, is communicated
to the
user while the lamps and the circuitry are effectively encased within the
spaced wall
structure. A smooth seamless surface is thus presented to the user that is
properly
spaced for the desired therapeutic treatments, yet provides improved
ventilation so that
an aesthetic and appealing device surface is presented to the user that
minimizes user
discomfort. Other benefits relate to the adjustability of the device in the
form of a
flexible mask which forms upon user receipt to match a treatment surface,
e.g., a head
size, of the user. Smart componentry not only measures device usage, but may
also
calculate lamp degradations so that a time for proper replacement can be
communicated to a user. The overall assembly is purposefully constructed of
relatively
light weight and minimized componentry for ease of user use and comfort.
[0086] More particularly, and with reference to FIGS. 1-4, subject
embodiments
preferably comprise a lamp platform A and a remote battery pack B. The
platform A is
comprised of a wall structure 10 encasing the plurality of therapeutic lamps
such as red
and blue LEDs 12 and circuitry 14 for communicating power to the lamps via
cable 80
and connector 83 from the battery pack B. Other radiant energy forms could
also
include fluorescents, lasers or infrareds. The wall structure 10 is mounted on
a support
frame 20 connected via snap-out pivotal connections 22 which allows the wall
structure
to adjust position via a slight pivot relative to the frame 20. The frame 20
also includes
protective lenses 24 and a nose bridge 26. The temple arms 28 may be fixed or
telescopic and hinge relative to the frame 20 so that the platform A can be
mounted on
a user in a hands-free support manner via resting on the nose with the nose
bridge 26
and the ears with temple arms 28.
[0087] With reference to FIGS. 3, 4, 6, 7 and 8 it can be seen that the
wall structure
is comprised of an outer wall 50 and an inner wall 52. The outer wall is
disposed
16

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
furthest away from the treatment surface of the user, while the inner wall 52
is disposed
closer thereto. The walls have a concave configuration in both horizontal and
vertical
directions and are constructed of a plastic material having a malleable
rigidity so that
the structure 10 can be bent and deflected slightly during use. The concavity
comprises
a multi-dimensional parabolic curvature for catching and reflecting the
radiation back to
the treatment areas. It is intended that the concavity is slightly smaller
than the head of
the user so that the mask has to be bent out when applied thereby providing a
close but
comfortable tightness on the user which will keep the assembly A in a desired
position
during use. The concavity also positions the therapeutic lamps or LEDs 12 in
desired
positions relative to the user. The spacing 54 between walls 50 and 52
receives the
lamps 12 and circuitry 14 so that the lamps and circuitry are interposed
between the
walls for enhanced safety and convenience purposes. It can be seen that the
spacing is
diminished from the middle of the device towards the end portions 58, 60;
however, the
entire end perimeter of the assembly 10 is sealed as the walls come together.
Such a
mating seal is typically effected through a sonic weld arrangement.
Alternatively, local
sealing points (not shown) can be employed to assemble the walls together with
spaced
intermediate seals. Thus, the inner and outer masks have different radii of
concavity
but present an integral structure as far as the user is concerned. The outer
wall 50
primarily functions as a support for the lamps 12 and circuitry 14. With
reference to
FIG. 4 it can be seen that the lamps are disposed on the wall 50 in a
predetermined
manner for radiating treatment areas most susceptible for the phototherapeutic

treatment. A minimum number of lamps 12 are intended but still enough to
provide
effective therapy.
Alternatively, the lamps could be fixed to the inner wall 52.
Regardless of which wall supports the lamps, the lamps need to be properly
aligned
with apertures 70 to desired treatment areas.
[0088]
Rather than placing a plurality of LEDs randomly, the subject LEDs are
specifically minimized in number and disposed relative to the treatment areas
and wall
parabolic reflectivity to effect the desired therapy. More particularly, it
can be seen that
the individual lamps 12, and associated inner wall apertures 70, are disposed
to treat
the most common areas benefiting from the therapy. The present embodiments
illustrate a placement pattern useful for skin acne treatment. Other placement
patterns
17

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
are certainly intended to fall within the scope of the disclosed embodiments.
Here three
LED strips are seen and would typically comprise two blue strips on the top
and bottom
of a middle red strip, as these frequencies are most useful for acne
treatment. The
subject invention may include only blue, only red, or any other mixed
combination of
LED or other radiant energy form pattern. The illustrated pattern would thus
have
intensified therapeutic effect on the jaw line, chin, cheek and forehead, but
not the
eyelids. Light sources can include LEDs, fluorescents, lasers or infrareds as
an
example. Such sources can vary in the form of the radiant energy delivery.
Pulsed light
(IPL), focused light (lasers) and other methods of manipulating light energy
are
encompassed within the present embodiments. Other methods of light emission
may
comprise continuous, pulsed, focused, diffuse, multi wavelength, single
wavelength,
visible and/or non-visible light wavelengths.
[0089] The inner wall 52 is comprised of a smooth seamless reflective
surface facing
the treatment area and includes a plurality of apertures 70 matingly aligned
relative to
the lamps so that the lamps can radiate the therapeutic light 57 through the
apertures
70. Accordingly, the LEDs 12 are recessed relative to the inner wall 52 to
preclude
contact with the treatment surface and to make it very difficult for the lamps
themselves
to be in any way contacted by the user. Such an assembly results in a
controlled
communication of radiating therapy in a manner to impart a predetermined cone
of
therapeutic light on to a treatment area. The apertures are disposed relative
to desired
treatment areas and wall parabolic configuration for even light distributions
across the
treatment area. A combination of such a controlled cone of light,
predetermined
disposition of the lamps themselves on the platform, an inner reflective
surface on the
inner wall 52, and a controlled positioning of the assembly relative to the
treatment area
via a platform position relative to contact areas of the nose and the ears,
presents an
assembly which presents a highly predictable distributive pattern of the light

(predetermined cones of light per light source), thereby minimizing the number
of lamps
12 that need to be included for effective treatment.
[0090] With reference to FIGS. 2, 3 and 4, one embodiment comprises a
support
frame essentially comprising eyeglass frames as the associated support
structure for
the platform 10. Interchangeable lenses 24 can be used to adjust the level of
protection
18

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
afforded by the lenses or their relative shape. Although not shown therein,
telescopic
temple arms 28 may telescope for better sizing relative to the head size of
the user.
Formable ear latches can also be included as part of the temple arms.
Alternatively, the
arms could include a head strap. The pivotable joints 22 allow the wall
structure to pivot
relative to the frames so that a user may adjust light intensity relative to a
treatment
area by moving the layers closer or farther away. As noted above, the platform
10 is
flexible with a concave parabolic bias, but still has a malleable rigidity.
When the frame
is received on the user, it is disposed to expand the platform parabolic bias
to form a
match to the size of the user. Eyeglass frame reference contact points of the
user may
comprise the nasion area, the nose bridge and the ears of the user.
Alternatively, the
support frame can comprise a goggle and head strap configuration relying on
the nasion
area.
[0091] Battery pack B (FIG. 5) holds the supply batteries 81 and processing
controller 82 that is in electrical communication with the lamps through wire
80. The
wiring between connectors 83 and LED strips 12 is not shown to avoid drawing
clutter
but is contained between walls 50, 52. The battery pack will include an on-off
switch 84
and a user interface 86. The processing controller 82 may include a variety of
control
systems indicating device usage to the user. Such a system would be a counter.
The
user interface may comprise a display for a variety of useful information from
the
controller control systems to the user, such as a count of the number of times
of usage
and communication that the device has been used enough times such that the
LEDs
themselves have degraded and a replacement is recommended for the therapy.
[0092] "Try-me packaging", FIGS. 11 and 12, presents a demonstrative use
opportunity to a potential user while still packaged. The subject embodiments
further
include a packaging assembly 210 containing the device wherein a switch 51
(not
shown) for operating the lamp assembly has a multi-position effect
functionality
including an on-mode, an off-mode and a try-me mode. The try-me mode is
accessible
while the lamp assembly is contained in packaging for displaying lamp
operation to a
user. The packaging includes a clear or translucent cover 212 over the device
A. A try-
me time-out circuit is included for limiting the try-me display time of lamp
operation,
such as, for example two seconds. Lamp on-time as measured by the counter is
19

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
segregable from the try-me mode so that try-me usage will not affect dosage
count of
the device for actual therapy. It is assumed try-me usage time will be
negligible relative
to a dosage use time.
[0093]
The subject devices include multiple benefits to the user in a wearable hands-
free device with a remote battery pack. The device is properly positionable in
a
relatively automatic way with minimal human touch by exploiting user reference
contact
points, and is particularly hand-free during use.
No sharp or hot surfaces are
engageable by the user. A smooth seamless surface faces the user and is
properly
spaced from the treatment area to provide enhanced ventilation and minimal
discomfort
during treatment.
[0094]
With particular reference to FIG. 14, a flowchart illustrating an operational
embodiment of a device control is illustrated. The device visioned as
operational by
FIG. 10 includes two switches, Si, S2, at least one of which are required to
be closed to
communicate energy from an energy source to the therapeutic lamps. S2 is a
safety
switch which is open when the device is in sales packaging so that only the
"try-me"
mode is enabled when S2 is open. After removal from the packaging, S2 can be
closed
and the device can be operated in a normal mode. Accordingly, after start 100,
and in a
situation when S2 is opened 102, such as when the device is still within the
packaging,
the system will remain in a stand-by mode wherein the GUI interface (such as a
LCD) is
off 104. If S2 remains closed 106 but Si is pressed 108 (e.g. FIG. 12), then
the device
can enter the "try-me" mode 110 wherein the LEDs will light up for two
seconds, then
turn off 112. Such a "try-me" mode operational demonstration to a user while
the
device is in a packaging communicates to the user actual operation and can
assist in a
decision to purchase, or have a better understanding of how the device
operates. If the
device is removed from the packaging, and S2 is closed, the device will enter
normal
mode 114 wherein the GUI will include a LCD displaying the number of cycles
left
according to a counter value 116. Note that counter value 134 is not affected
by any
try-me sampling operation.
[0095]
In one embodiment, the unit will count down from 55 to 1, as 55 uses is
deemed to be enough to diminish enough LED efficiency from the peak
operational
mode of LEDs when they are used as the therapeutic radiant lamps. Accordingly,
upon

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
a user picking up the device, they will immediately know how many cycles are
left for
acceptable and recommended operation of the device from 55 more uses all the
way
down to 0 118. If the display shows a count greater than 0, and the user is
interested in
a therapy session, the user will turn the unit on by pressing Si 120 wherein
the LEDs
will ramp up to radiant operation 122 in approximately 1.5 seconds and then
will radiate
continuously 124 until either the user desires to turn off the unit by again
pressing Si
126 so that the LEDs can ramp down 128 or until a therapy session has timed
out 130
such as for remaining radiant for approximately ten minutes. After completing
an
appropriate run time of a therapy session, the LEDs will ramp down 132 and the
GUI
display to the user will subtract 1 from the counter value 134.
[0096] With reference to FIGS. 9 and 10, an alternative embodiment is shown
wherein a controller B is eliminated and the energy source and processing
control are
all integrally assembled in the device 90. In this case, the platform 20 and
walls 50, 52
remain substantially the same as per the FIG. 1 device. However, the energy
source
such as batteries 92 are disposed as part of the eyeglass temple arms wherein
wires
provide energy from the batteries 92 to the LEDs through the hinge points of
the frame
20 and into the spacing 54 for ultimate connection to the LEDs themselves. The

controller 94 including LCD display 96 is also housed behind the reflective
wall 52
relative to the user, which wall 52 can include a relatively small cutout (not
shown) for
the screen 96.
[0097] The embodiment of FIGS. 9 and 10 is thus even more compact than the
embodiment of FIG. 1, and more hands-free therefrom, as it eliminates the need
to
somehow manage the controller B during operation.
[0098] FIGURE 11 shows yet another alternative embodiment wherein the outer
wall
50' and the inner wall 52' are not spaced by being configured with different
curvatures.
Rather, the walls 50', 52' have the same curvature, but the inner wall 52 has
an off step
300 depending from the wall perimeter to form a flange raised from the surface
of the
wall 52' towards the outer wall 50' to effectively form a spacer between the
two. In one
embodiment, the flange 300 is about 8 millimeters wide, continues around the
entire
perimeter of the wall 52' and is about .5 millimeters thick for effecting the
desired
spacing between the inner and outer walls. In this embodiment the flange 300
is part of
21

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
the inner wall 52', and as in the foregoing embodiment, both walls are
vacuumed formed
plastic, either PET or PVC. The assembly of FIG. 11 can be sonic welded,
glued, or
adhered with double-sided adhesive. Alternatively, a plurality of intermediate
sealing
points (not shown) could be used instead of a continuous seal. In this
embodiment it
can be seen that there is an alternative number of LEDs 12' opposite the
forehead
portion of the assembly relative to the user so that the number of apertures
70' and
LEDs 12' are reduced from the foregoing embodiment from eighteen to fifteen.
Either
number are viable implementations of the desired therapy, although the other
componentry of the assembly FIG. 11 is substantially the same as that shown in
the
foregoing figures.
[0099] Another alternative embodiment from the device shown in FIGS. 1,
etc.
includes disposition of a transparent flexible polymer sheet (not shown)
incorporating
working LED lights between outer wall 50 and inner wall 52. Such a
configuration would
comprise the polymer film being coated with a transparent thin layer of carbon

nanotubes in a specific configuration to act as the wire pathways to connect
LED lights.
The polymer would protect the LEDs from user contact. Such protective polymers
are
available under the Lumisys brand.
[00100] Yet another alternative embodiment includes such a transparent
flexible
polymer sheet wherein a reflective film is applied on top of the flexible
polymer sheet
including cutouts opposite the LEDs for allowing the radiant light to
communicate
through a reflective area in a manner as shown in the relationship of FIG. 4
between the
LEDs' 12 inner wall 52 through aperture 70. This arrangement may also include
a
flexible outer wall 50 on the other side of the flexible polymer sheet to
provide malleable
rigidity to the film, reflective coating assembly.
[00101] Yet another alternative embodiment includes a plurality of sensors
(not
shown), such as temperature or radiant energy sensors, disposed relative to
inner wall
52 to monitor radiant energy exposure of a user during therapy. If such
exposure is
deemed inappropriate for any reason, sensing thereof is recognized by
controller B and
the therapy can be halted.
[00102] FIG. 15 shows yet another alternative embodiment including an outer
shield
150 including a see-through slot 152, an inner reflective shield 154, and
eyeglass
22

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
assembly 156, and LED strips 158. These elements are substantially similar,
but for the
see-through slot 152 and corresponding aligned slots, as the foregoing
embodiments.
Alternatively, this embodiment includes a third layer 160 intermediate the
outer shield
150 and the inner shield 154. Layer 160 preferably comprises a thin opaque
black
plastic sheet which serves to absorb or block out lamp radiation and eliminate
all light
leakage from the front of the mask, i.e., out through the outer shield 150.
Layer 160 is
preferably affixed to the inside of the outer layer 150 and then the LED
strips are affixed
to the layer 160. The strips 158 still remain recessed relative to the inner
surface 162 of
the inner shield 154 for the benefits noted above. FIG. 15 also shows a
controller
assembly cable 164 and an eyeglass assembly mounting post 166. The eyeglass
assembly lenses 168 are tinted but do not preclude a user to see through the
inner
shield slot 170, the third layer slot 172 and the outer shield see-through
slot 152. The
aligned slots 152, 170, 172 comprise a continuous viewing opening that is an
integral
part of the mask. A layer 160 is sized to provide perimeter spacing from the
outer
perimeter of the outer shield 150. When the unit is operating and the LEDs are

illuminated, this provides a perimeter illumination to an observer of the user
which not
only communicates that the unit is in operation but provides an aesthetically
pleasing
appearance.
[00103] In one embodiment the LED strips 158 are preferably attached to the
intermediate third layer 160 by being received in corresponding pockets (not
shown) in
the layer 160. Alternatively, they can be adhesively applied to the layer 160.
The wires
between the strips 158 are very thin and just rest between the middle layer
and the
inner shield 154, i.e., no special wire routing. There is accommodation for
the main
cable and strain relief ¨ leading to the first LED strip. The whole middle
layer assembly
fits into the chamfered recess in the inner shield 154, and there are locating
points
top/bottom and left/right. This is secured with double-sided tape. The middle
layer/LED
strips/inner shield assembly is completed by the outer shield 150 (also by
double-sided
tape). There are several sonic welds 180 (FIG. 16) that permanently secure the
layers
together. Assembled perspective views 174, 176 are shown. FIG. 16 (A), (B),
(C), and
(D) illustrate elevated views of the embodiment of FIG. 15 when assembled.
[00104] FIG. 17 is yet another alternative embodiment which differs from the
23

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
embodiment of FIG. 15 in that the see-through slots 152, 170, 172 have been
eliminated and the eyeglass assembly 190 no longer has tinted lenses, but
radiant light
blocking goggles 192. Like elements from FIG. 15 are same numbered and primed.
In
this embodiment, the eyes are to be protected from any of the radiant energy
emitted by
the lamps. Such an embodiment is particularly useful for a phototherapeutic
treatment
of red and infrared light for an anti-aging therapy. A red light evens skin
tone and
reduces roughness. Infrared light reduces the appearance of fine lines and
wrinkles.
However, whatever radiant energy may be employed, the goggles 192 completely
shield the eyes from the radiant energy.
[00105] FIG. 18 is yet another embodiment where the mask assembly 220 is sized
to
only treat the eye area of a patient so that the assembled mask is much
smaller than
that shown in FIG. 17. The LED strips 158" are disposed in a different
arrangement
from that FIG. 16 but the other elements are essentially the same including
the
protective goggles 192".
[00106] It is a common feature of the embodiments described thus far that the
LED
lamps remain recessed relative to the inner surface 162 of the inner shield
154 for
comfort and safety purposes relative to the user.
[00107] With reference to FIGS. 19A and 19B, illustrated is a front view and
side view
respectively of a therapeutic lamp platform controller including a SIM
cartridge refill
according to an exemplary embodiment of this disclosure.
[00108] As shown, the controller includes a battery charger port 302, a charge
state
indication 304, a LCD display 306, an On/Off button 308, a dosage refill
cartridge 310
and a cable 312 which is operatively connected to a light therapy platform
mask.
[00109] The SIM cartridge refill 310 provides a manner for a user to purchase
additional dosages for the device. For example, a user may purchase a SIM
cartridge
refill cartridge which authorizes an additional 30, 60, or 90 dosages. In
operation, the
controller communicates with the SIM cartridge after the user attaches to the
device and
a series of program instructions are performed to validate the SIM cartridge
and activate
an additional number of available dosages to be delivered by the device. In
addition,
controller program instructions are provided to deactivate the use of SIM
cartridge refill
after the controller dosage counter has been increased by the SIM cartridge
refill
24

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
replenishment dosage amount.
[00110] With reference to FIG. 20, shown is a schematic of a first therapeutic
lamp
platform controller as shown in FIG. 5, according to an exemplary embodiment
of this
disclosure.
[00111] As shown, the controller includes a microcontroller U1 which executes
program instructions based on a control program, as well as inputs associated
with
switch SW1 (On/Off Button), S2 (Try Me Switch) and switch S4 which resets the
device.
The microcontroller U1 drives a 4x4 LCD as well as the lamp radiation LEDs D1-
D18
using circuitry including capacitors C4, C3, C6, C5, and C10, Batteries B1 and
B2,
Resistors R70, R80, R9, R10, R11, R12, R13, R14, R15, R8, R22, R23, R21, R20,
RR19, R18, R17, and R16, and driver circuit including resistor R2, and
transistor Q1.
[00112] With reference to FIG. 21A, illustrated is a perspective view of
another
second therapeutic lamp platform controller according to an exemplary
embodiment of
this disclosure, and FIG. 21B, shows an exploded view of another second
therapeutic
lamp platform controller according to an exemplary embodiment of this
disclosure.
[00113] As shown, the controller 320 includes a front housing 322, a LCD
display 324,
an On/Off button switch 326, a PCB 328, a rear housing 338, a plurality of
batteries 344
and a battery cover 348.
[00114] With reference to FIGS. 22A and 22B, illustrated is a schematic of the
second
therapeutic lamp platform controller shown in FIG. 21, according to an
exemplary
embodiment of this disclosure.
[00115] As shown, the controller includes a microcontroller U1 which drives
LCD 1,
and communicates with microcontroller U2 which is housed within a mask. The
circuitry
shown in FIG. 22A resides in the controller and the circuitry shown in FIG.
22B resides
in the mask.
[00116] By operating a second microcontroller housed within the mask,
microcontroller U1 can execute instructions to determine if a mask is
authorized to be
operated by the controller.
[00117] In contrast to the controller illustrated schematically in FIG. 20,
the controller
shown in FIG. 22A includes circuitry to monitor various states of the battery
to provide

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
notification to a user that the battery requires charging/replacement, in
addition to
insuring adequate power for executing an active dosage request.
[00118] With reference to FIG. 23, shown is a flow chart of the operational
control of a
therapeutic lamp platform according to an exemplary embodiment of this
disclosure, the
operational control including a Stand-By Mode, Normal Mode, Test Mode and
Configure
Mode.
[00119] With reference to FIG. 24, illustrated is a flow chart of the
operational control
of a Normal Mode S368 associated with a therapeutic lamp platform controller
according to an exemplary embodiment of this disclosure.
[00120] At step S392, the control program determines if a dosage counter value
is 0,
and if true proceeds to step S394 to display "0" notifying the user that the
controller
requires additional dosage authorization or replacement, and then proceeds to
exit to
Stand-By Mode at step S364.
[00121] If the dosage counter is greater than 0, the control program proceeds
to step
S398 to determine if the battery voltage is low. If a low battery voltage
condition is
detected, the control program proceeds to step S400 and enters Battery Charge
Mode.
[00122] If the battery voltage is acceptable, the control program executes
step S402
to display "Hi" and step S404 displays the dosage counter.
[00123] At step S406, the control program waits for the On/Off button to be
pressed
for 1 second, where the control program exits to Stand-By Mode if switch 51 is
not
pressed for 1 second. After 51 switch is pressed for 1 second, the control
program
proceeds to step S412 to determine if the mask is authorized to be operated
with the
controller.
[00124] If the mask is not authorized, the control program flashes "00" two
times on
the LCD at step S410 and then proceeds to Stand-By Mode at step S408. If the
mask is
authorized, the control program proceeds to step S414 to ramp up power to the
LEDs in
0.5 seconds, and step S416 to turn the LEDs continuously "On", step S418 to
start the
LCD countdown indicating the amount of time remaining for the current active
dosage
session.
[00125] At step S420, the control program monitors 51, where the user pressing
the
On/Off button for 1 second will initiate the terminating of the active dosage
session by
26

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
the control program executing step S424 to ramp-down the LED power in 1.5
seconds,
step S426 to decrement dosage counter by 1, step S428 to display on the LCD
the
remaining number of dosages available and step S364 to exit to Stand-By Mode.
[00126] If, at step S420, switch 51 is not pressed, the control program
executes step
S422 to monitor the time expired for the current active dosage session and
executes
steps S416, S418, S420 and S422 until the dosage time limit has been reached,
at
which point steps S424, S426, S428 and S364 are sequentially executed during
an LED
power down process as previously described.
[00127] With reference to FIG. 25, shown is a flow chart of the operational
control of a
Battery Charge Mode S400 associated with a therapeutic lamp platform
controller
according to an exemplary embodiment of this disclosure.
[00128] As shown, the control executes step S432 to blink "Lo" on the LCD
continuously to notify the user the battery is low, and if the user presses
the On/Off
control switch (51) while the battery is low, step S436 blinks the mask LEDs
to provide
additional notification to the user the battery needs recharged/replaced.
[00129] With reference to FIG. 26, illustrated is a flow chart of the
operational control
of a Configuration Mode S380 associated with a therapeutic lamp platform
controller
according to an exemplary embodiment of this disclosure.
[00130] As shown, the controller executes step S442 to get a "Start Dose"
value via
Tx/Rx, where step S444 sets the dosage limit at 30 doses, step S446 provides
60 doses
and step S448 provides 90 doses.
[00131] At step S450, the control program displays the "Start Dose" value
selected,
and at S452 the "Counter Value" is set to the value selected, i.e. 30, 60, or
90 doses.
[00132] At step S364, the control program exits to Stand-By Mode.
[00133] As shown, after the control program enters Test Mode, step S462 is
executed
to provide a LCD Quick Display Test, step S464 displays the LCD bonding
status, step
S466 sets "Display Value" to (31 "=05", step S468 blinks "Display Value" and
step S470
proceeds to exit to Stand-By Mode at step S364 unless switch S3 is closed by
the user,
in which case the control program proceeds to step S472 and if 51 is not
pressed, the
control program repeats execution of step S468. If switch 51 is pressed, the
control
27

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
program proceeds to step S474 and compares the counter dosage value with the
start
dosage value.
[00134] If the counter dosage value is not equal to the start dosage value,
the control
program returns to step S468, otherwise step S478 lights up the LEDs for 2
seconds
and step S476 decrements the displayed dosage counter value.
[00135] At step S480, if the display value equals 0, then the control program
proceeds
to step S468, otherwise the control program proceeds to step S482 and displays
"00"
for 2 seconds and then exits to Stand-By Mode at step S634.
[00136] With reference to FIG. 27, shown is a flow chart of the operational
control of a
Test Mode S372 associated with a therapeutic lamp platform controller
according to an
exemplary embodiment of this disclosure.
[00137] With reference to FIG. 28, illustrated is a flow chart of the
operational control
of a Stand-By Mode S949 associated with a therapeutic lamp platform controller

including an independent mask controller configured to determine authorization
of a
mask/controller combination, according to an exemplary embodiment of this
disclosure.
[00138] As shown, at step S496, the mask controller receives an authorization
query
from the controller.
[00139] At step S498, the mask controller determines if the controller/mask is

authorized to be operated, where step S500 denies power to the LEDs if proper
authorization is not obtained and S502 allows power to the LEDs if the
controller/mask
is authorized.
[00140] With reference to FIG. 29, shown is a system diagram including a
therapeutic
lamp platform controller 320 simultaneously powering a plurality of
phototherapy
devices, including an Eye Mask 512, a Décolletage Device 514 and a Hand
Rejuvenation Device 516, operatively connected with cable 518. According to an

exemplary embodiment, the controller multiplexes electrical power delivered to
the
phototherapy devices to utilize a limited power capacity of the device.
Alternatively, the
controller can include a sufficient battery capacity to drive all devices
continuously
and/or include separate LED driving circuits, one for each device.
[00141] Simultaneous powering of multiple phototherapy devices provides a
manner
of treating multiple user treatment areas at the same time. According to one
exemplary
28

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
embodiment, multiple treatment areas of a user's body are treated with one
single
dosage period. Alternatively, multiple dosage periods can be used where each
device
utilizes one dosage period. In addition, the controller is configured to
execute program
instructions to authenticate any device operatively attached to controller 320
via cable
518, for example, by executing a data handshake with the phototherapy device.
[00142] With reference to FIG. 30, illustrated is a mobile device 524
operatively
associated with powering a therapeutic lamp platform 522 using an operating
connected
cable according to an exemplary embedment of this disclosure.
[00143] According to an exemplary embodiment, the therapeutic lamp platform
522 is
a reusable mask and mobile device 524 is a smart phone. The smart phone
provides a
platform to conduct ecommerce through the use of a lamp platform application
where a
user can electronically purchase additional dosages to be delivered by the
mask 522.
Cable 526 provides both power to the LEDs and enables authorization of the
mask to
"turn on", verifying that the user has a valid dose remaining, where circuitry
housed
within the mask communicates with the smart phone.
[00144] Due to power limitations, i.e. limited current draw, associated with
some
mobile devices, power to the mask LEDs can be multiplexed. For example, a
smart
phone supplies power at 3.5 volts at 150 mA to the mask, and control circuity
housed
within the mask multiplexes the array of mask LEDs to provide a reduced amount
of
radiation to the user treatment area, where an increased dosage period of time
may be
provided by the controller.
[00145] In addition to providing powering of the mask, the mobile device also
can
provide functionality and control of the mask. In other words, the mobile
device provides
the controller functionality previously described and also additional
functionality, such as
tracking of skin improvement using images of the treatment area captured by
the mobile
device camera.
[00146] With reference to FIG. 31, shown is a detail view of the mobile device
shown
in FIG. 30.
[00147] With reference to FIGS. 32A and 32B, illustrated is a therapeutic lamp

platform including an inductively charged mask 532 with an integrated
controller,
29

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
rechargeable battery, and inductive charger 534, according to an exemplary
embodiment of this disclosure.
[00148] With reference to FIGS. 33A and 33B, shown is the magnetic docking of
an
inductively charged therapeutic lamp platform 532 on an inductive charger 534
according to an exemplary embodiment of this disclosure.
[00149] With reference to FIGS. 34A, 34B and 34C, further illustrated is the
magnetic
docking of an inductively chargeable therapeutic lamp platform 542 according
to an
exemplary embodiment of this disclosure.
[00150] As shown, the inductive charging system includes a mask 542 and an
inductive charger 544. The mask 542 includes a charger coil 546 and the
inductive
charger 544 includes a corresponding charger coil 544. In addition, the mask
542
includes a light 550, a controller 552 and LED strips 554. During a charging
operation,
the mask charger coil 546 and the inductive charger coil 544 are operatively
mated on
the charging dock to inductively charge the mask battery, as shown in FIG.
34C.
[00151] With reference to FIGS. 35A and 35B, shown is a corded 568 therapeutic

lamp platform 562 including an inductively charged controller 566 and
inductive charger
564.
[00152] With reference to FIG. 36, illustrated is an exploded view of the
inductively
charged therapeutic lamp platform 532 shown in FIG. 32.
[00153] As shown, the therapeutic lamp platform 532 includes a mask trim 572,
outer
layer 574, middle layer 576, LED strips 578, inductive charging assembly 580,
locator
plate 582, a PCB 584, inner layer 586, trim 588, eyeglass frame 590, LIPO
battery 592
and trim 594.
[00154] According to an exemplary embodiment of a light therapy platform
inductive
mask and charger, the mask includes a parabolic shape, comfort glasses, 27
LEDs,
view through window and integrated power button. The inductive charging
technology
shown in the figures provides wireless charging of the mask. In addition,
magnetic
docking the charger converts 110 VAC ¨> an appropriate DC charging voltage,
such as
VDC, and the magnetic alignment using the coils previously referred to provide
for
optimal alignment of the mask with the charger to efficiently charge the mask
battery.

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[00155] With reference to FIG. 37, illustrated is a combination therapeutic
lamp
platform mask 600 providing for a plurality of treatment radiation
combinations, e.g.
Acne and Anti-Aging, according to an exemplary embodiment of this disclosure.
[00156] As shown, the combination therapeutic lamp platform includes mask
structure
602, eyeglass frame 604, eye covers 606, LED1 608, LED2 610, LED3 612, and
cable
614 which is operatively connected to a controller.
[00157] During operation, a user can select a desired treatment from one of a
plurality
of treatments provided by the mask LEDs placement, radiation wavelength and/or

controller configuration.
[00158] With reference to FIG. 38, illustrated is another combination
therapeutic lamp
platform mask 620 providing for a plurality of treatment radiation
combinations, e.g.
Acne and Anti-Aging, according to an exemplary embodiment of this disclosure,
where
a lens 622 is provided.
[00159] Other variations of the combination lamp platform mask include a
specific
layout of LEDs for each treatment, for example anti-aging radiation LEDs
aligned to
areas of the face normally affected by age. Another example includes aligning
acne
LEDs to key facial features in the T-zone and around the jawline.
[00160] Furthermore, control variations include a combination treatment where
all
LEDs are radiating simultaneously to provide a plurality of treatments, such
as acne and
anti-aging; configurable controller settings for a user to choose a specific
treatment and
treatment schedule; and configurable controller settings to program the mask
to start
with a first treatment and run until completion and then begin a second
treatment.
[00161] According to another exemplary embodiment of a combination lamp
platform,
multi-color LEDs are mounted to the mask, the multi-color LEDs wavelength,
i.e. color,
controllable by the device controller to select a treatment regimen they would
like to
implement and the appropriate LEDs, along with radiation wavelength, are
activated.
Other control options include cycling the LED colors through various treatment
modes,
providing simultaneous treatment of multiple skin conditions, and allowing the
user to
program which areas of their face require specific treatments, e.g. acne on
the forehead
and anti-aging around smile lines, where the control software turns on the
appropriate
LED in these specific facial regions. Furthermore, the combination lamp
platform can be
31

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
connected to a mobile device such as a smart phone with a dedicated
application, an
image of the user treatment area captured by the smart phone and the software
application performs an analysis of the user's skin condition(s) and custom
tailors the
LED treatment regimen based on the image analysis.
[00162] With reference to FIGS. 39A and 39B, illustrated is a therapeutic lamp

platform configured to stimulate hair growth according to an exemplary
embodiment of
this disclosure.
[00163] As shown in FIG. 39A, the therapeutic lamp platform, i.e., hair growth
light
therapy device 630, includes a LED 636 support structure 632 attached to a
head band
634. FIG. 39B shows a hair growth light therapy device 640 including an
extended LED
support structure 642 for additional coverage of a scalp.
[00164] To use the device 630, a user uses the headband 634 to removably
attach
the device to the scalp area, where the placement of the headband behind the
users
ears provide positioning of the LEDs as indicated.
[00165] With reference to FIGS. 40A and 40B, illustrated is a therapeutic lamp

platform configured to stimulate hair growth including an integrated comb 652
according
to an exemplary embodiment of this disclosure. The integrated comb bristles
provide
parting of hair to improve the efficiency of the radiation treatment provided
by LEDs 636.
[00166] With reference to FIGS. 41A and 41B, shown are detail views of
LED/Brush
Bristle configurations for a therapeutic lamp platform 630 and 640 configured
to
stimulate hair growth. Part lines 662 are provided by brush/bristles 652, and
a recessed
hair line is indicated as reference character 664 and crown area by reference
character
666.
[00167] With reference to FIGS. 42A and 42B, illustrated are detail views of
radiant
energy scalp coverage 674 and 684 associated with an exemplary embodiment of a

therapeutic lamp platform configured to stimulate hair including LEDs 636
without an
associated light pipe, and with an associated light pipe 682, respectively.
[00168] As shown in FIG. 42A, the therapeutic lamp platform includes an outer
housing 672, and LED 636 with generating radiation cone 674 providing hair
growth
coverage on a scalp 676, including hair follicles 678.
32

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[00169] In comparison, FIG. 42B includes a light pipe 682 which provides a
radiation
cone 684 which is narrower than radiation cone 674, but has the advantage of
an
increased in radiation intensity for a given controller output, controlled by
the light pipe
diameter.
[00170] With reference to FIGS. 43A and 43B, shown are further detail views of

radiant energy scalp coverage associated with a therapeutic lamp platform
without a
light pipe and with a light pipe, respectively, as shown in FIGS. 42A and 42B.
[00171] With reference to FIGS. 44A and 44B, illustrated is another
therapeutic lamp
platform 690 and 700 configured to stimulate hair growth including a helmet
design with
an eye glass frame 696 reflective layer 702 and lens 694, according to an
exemplary
embodiment of this disclosure.
[00172] With reference to FIG. 45, shown is a detail view of an LED
configuration of a
therapeutic lamp platform configured to stimulate hair growth as shown in
FIGS. 44A
and 44B, where LEDs 636 are aligned along part lines 662 associated with
recessed
hair line 664 and crown 666. Area 704 is associated with an extended coverage
area
provided by the lamp platform. This configuration provides a radiation bath
which
targets all problem areas at once. A reflective layer attached to the inside
surface of the
helmet provides a more intense treatment.
[00173] With reference to FIGS. 46A and 46B, illustrated is another
therapeutic lamp
platform configured to stimulate hair growth including a helmet 710 according
to an
exemplary embodiment of this disclosure. The hair growth lamp platform
includes a
plurality of LEDs mounted to a shell 712, where an adjustable tensioner 714
and knob
arrangement control the fitting of the helmet to a user's head. Extra padding
at the back
of the helmet provides additional support and comfort.
[00174] With reference to FIG. 47, shown is a detailed view of an LED 636
configuration of a therapeutic lamp platform as shown in FIGS. 45A and 45B,
configured
to stimulate hair growth according to an exemplary embodiment of this
disclosure. As
shown, the detailed view includes a crown area 666, recessed hair line area,
and part
lines 662 which are substantially aligned with LEDs 636.
[00175] Some portions of the detailed description herein are presented in
terms of
algorithms and symbolic representations of operations on data bits performed
by
33

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
conventional computer components, including a central processing unit (CPU),
memory
storage devices for the CPU, and connected display devices. These algorithmic
descriptions and representations are the means used by those skilled in the
data
processing arts to most effectively convey the substance of their work to
others skilled
in the art. An algorithm is generally perceived as a self-consistent sequence
of steps
leading to a desired result. The steps are those requiring physical
manipulations of
physical quantities. Usually, though not necessarily, these quantities take
the form of
electrical or magnetic signals capable of being stored, transferred, combined,

compared, and otherwise manipulated. It has proven convenient at times,
principally for
reasons of common usage, to refer to these signals as bits, values, elements,
symbols,
characters, terms, numbers, or the like.
[00176] It should be understood, however, that all of these and similar terms
are to be
associated with the appropriate physical quantities and are merely convenient
labels
applied to these quantities. Unless specifically stated otherwise, as apparent
from the
discussion herein, it is appreciated that throughout the description,
discussions utilizing
terms such as "processing" or "computing" or "calculating" or "determining" or

"displaying" or the like, refer to the action and processes of a computer
system, or
similar electronic computing device, that manipulates and transforms data
represented
as physical (electronic) quantities within the computer system's registers and
memories
into other data similarly represented as physical quantities within the
computer system
memories or registers or other such information storage, transmission or
display
devices.
[00177] The exemplary embodiment also relates to an apparatus for performing
the
operations discussed herein. This apparatus may be specially constructed for
the
required purposes, or it may comprise a general-purpose computer selectively
activated
or reconfigured by a computer program stored in the computer. Such a computer
program may be stored in a computer readable storage medium, such as, but is
not
limited to, any type of disk including floppy disks, optical disks, CD-ROMs,
and
magnetic-optical disks, read-only memories (ROMs), random access memories
(RAMs),
EPROMs, EEPROMs, magnetic or optical cards, or any type of media suitable for
storing electronic instructions, and each coupled to a computer system bus.
34

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
[00178] The algorithms and displays presented herein are not inherently
related to
any particular computer or other apparatus. Various general-purpose systems
may be
used with programs in accordance with the teachings herein, or it may prove
convenient
to construct more specialized apparatus to perform the methods described
herein. The
structure for a variety of these systems is apparent from the description
above. In
addition, the exemplary embodiment is not described with reference to any
particular
programming language. It will be appreciated that a variety of programming
languages
may be used to implement the teachings of the exemplary embodiment as
described
herein.
[00179] A machine-readable medium includes any mechanism for storing or
transmitting information in a form readable by a machine (e.g., a computer).
For
instance, a machine-readable medium includes read only memory ("ROM"); random
access memory ("RAM"); magnetic disk storage media; optical storage media;
flash
memory devices; and electrical, optical, acoustical or other form of
propagated signals
(e.g., carrier waves, infrared signals, digital signals, etc.), just to
mention a few
examples.
[00180] The methods illustrated throughout the specification, may be
implemented in a computer program product that may be executed on a computer.
The computer program product may comprise a non-transitory computer-readable
recording medium on which a control program is recorded, such as a disk, hard
drive, or the like. Common forms of non-transitory computer-readable media
include, for example, floppy disks, flexible disks, hard disks, magnetic tape,
or any
other magnetic storage medium, CD-ROM, DVD, or any other optical medium, a
RAM, a PROM, an EPROM, a FLASH-EPROM, or other memory chip or cartridge,
or any other tangible medium from which a computer can read and use.
[00181] Alternatively, the method may be implemented in transitory media, such

as a transmittable carrier wave in which the control program is embodied as a
data
signal using transmission media, such as acoustic or light waves, such as
those
generated during radio wave and infrared data communications, and the like.
[00182] It will be appreciated that variants of the above-disclosed and other
features
and functions, or alternatives thereof, may be combined into many other
different

CA 02989163 2017-12-11
WO 2016/209860 PCT/US2016/038612
systems or applications. Various presently unforeseen or unanticipated
alternatives,
modifications, variations or improvements therein may be subsequently made by
those
skilled in the art which are also intended to be encompassed by the following
claims.
WHAT IS CLAIMED IS:
36

Une figure unique qui représente un dessin illustrant l’invention.

Pour une meilleure compréhension de l’état de la demande ou brevet qui figure sur cette page, la rubrique Mise en garde , et les descriptions de Brevet , États administratifs , Taxes périodiques et Historique des paiements devraient être consultées.

États admin

Titre Date
Date de délivrance prévu Non disponible
(86) Date de dépôt PCT 2016-06-22
(87) Date de publication PCT 2016-12-29
(85) Entrée nationale 2017-12-11

Historique d'abandonnement

Il n'y a pas d'historique d'abandonnement

Taxes périodiques

Description Date Montant
Dernier paiement 2019-05-08 100,00 $
Prochain paiement si taxe applicable aux petites entités 2020-06-22 50,00 $
Prochain paiement si taxe générale 2020-06-22 100,00 $

Avis : Si le paiement en totalité n’a pas été reçu au plus tard à la date indiquée, une taxe supplémentaire peut être imposée, soit une des taxes suivantes :

  • taxe de rétablissement prévue à l’article 7 de l’annexe II des Règles sur les brevets ;
  • taxe pour paiement en souffrance prévue à l’article 22.1 de l’annexe II des Règles sur les brevets ; ou
  • surtaxe pour paiement en souffrance prévue aux articles 31 et 32 de l’annexe II des Règles sur les brevets.

Historique des paiements

Type de taxes Anniversaire Échéance Montant payé Date payée
Enregistrement de documents 100,00 $ 2017-12-11
Enregistrement de documents 100,00 $ 2017-12-11
Dépôt 400,00 $ 2017-12-11
Taxe de maintien en état - Demande - nouvelle loi 2 2018-06-22 100,00 $ 2017-12-11
Taxe de maintien en état - Demande - nouvelle loi 3 2019-06-25 100,00 $ 2019-05-08
Les titulaires actuels au dossier sont affichés en ordre alphabétique.
Titulaires actuels au dossier
JOHNSON & JOHNSON CONSUMER INC.
Les titulaires antérieures au dossier sont affichés en ordre alphabétique.
Titulaires antérieures au dossier
S.O.
Les propriétaires antérieurs qui ne figurent pas dans la liste des « Propriétaires au dossier » apparaîtront dans d'autres documents au dossier.

Pour visionner les fichiers sélectionnés, entrer le code reCAPTCHA :



  • Pour visualiser une image, cliquer sur un lien dans la colonne description du document. Pour télécharger l'image (les images), cliquer l'une ou plusieurs cases à cocher dans la première colonne et ensuite cliquer sur le bouton "Télécharger sélection en format PDF (archive Zip)".
  • Liste des documents de brevet publiés et non publiés sur la BDBC.
  • Si vous avez des difficultés à accéder au contenu, veuillez communiquer avec le Centre de services à la clientèle au 1-866-997-1936, ou envoyer un courriel au Centre de service à la clientèle de l'OPIC.

Filtre Télécharger sélection en format PDF (archive Zip)
Description du
Document
Date
(yyyy-mm-dd)
Nombre de pages Taille de l’image (Ko)
Abrégé 2017-12-11 2 72
Revendications 2017-12-11 3 81
Dessins 2017-12-11 48 1 739
Description 2017-12-11 36 1 937
Dessins représentatifs 2017-12-11 1 12
Traité de coopération en matière de brevets (PCT) 2017-12-11 5 186
Traité de coopération en matière de brevets (PCT) 2017-12-11 5 206
Rapport de recherche internationale 2017-12-11 5 158
Déclaration 2017-12-11 1 31
Demande d'entrée en phase nationale 2017-12-11 29 999
Page couverture 2018-02-26 2 44